Hancock Whitney Corp Sorrento Therapeutics, Inc. Transaction History

Hancock Whitney Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$7.41 - $10.99 $926,250 - $1.37 Million	-125,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $2,685 - $6,306	-382 Reduced 0.3%	125,000 $1.03 Million
Q4 2020 Feb 09, 2021	SELL	$5.76 - $11.95 $43,752 - $90,772	-7,596 Reduced 5.71%	125,382 $856,000
Q3 2020 Nov 05, 2020	SELL	$6.17 - $18.82 $229,906 - $701,270	-37,262 Reduced 21.89%	132,978 $1.48 Million
Q2 2020 Jul 30, 2020	BUY	$1.73 - $6.76 $294,515 - $1.15 Million	170,240 New	170,240 $1.07 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.